Anuh Pharma Approves Rs. 75 Cr Loan and Asset Investment for Expansion
FUNDRAISE
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 13 Oct 2026, 06:37 PM IST · BSE ID: 720eaf02-0d4d-476d-8157-ec295d84919e
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's directors decided to borrow up to Rs. 75 Crores to buy new factory equipment and grow its manufacturing abilities.
🤖 AI Summary
- Anuh Pharma approves availing loan up to Rs. 75 Crores for asset investment.
- Investment targets expansion of the company’s production capacity.
- Loan subject to finalisation of terms and applicable approvals.
- Board meeting held on October 13, 2026, considered this proposal.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Loan amount for expansion
up to ₹ 75 crs
🏢 How This Affects the Company
The investment in manufacturing assets and expansion of production capacity is intended to scale the company's output and potentially increase market reach.
The company will avail a loan of up to Rs. 75 Crores, increasing its debt obligations. This will be used for capital expenditure on manufacturing assets.
The company will acquire new manufacturing assets to boost its production capabilities and expand its operational scale.
Availing a loan increases financial leverage and associated interest payment obligations. Expansion also carries execution risks.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding this board decision.
👤
Who Is Affected
All shareholders are potentially affected by management's decision to invest in expanding production capacity through debt financing.
🔍
Management Signal
This decision signals management's intent to pursue operational growth and enhance manufacturing capabilities.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Finalisation of loan terms and conditions from lenders.
Receipt of all applicable regulatory and statutory approvals.
Disclosure of specific manufacturing asset acquisition details.
MEDIUM RISK
Financing through debt and execution of expansion plans introduce financial and operational risks.
💡 Investor Takeaway
Anuh Pharma's board approved availing up to Rs. 75 Crores via loan for manufacturing asset investment to expand production capacity, subject to terms and approvals.
⚖️ Strengths & Concerns
✅ Positives
- Board approval for significant capital expenditure up to Rs. 75 Crores for expansion.
- Clear intent to invest in manufacturing assets to enhance production capacity.
⚠️ Concerns
- The plan relies on securing a loan of up to Rs. 75 Crores, with final terms pending.
- Expansion is contingent on receiving all required applicable approvals.
❓ Frequently Asked Questions
What was approved by Anuh Pharma's Board of Directors on October 13, 2026?
The Board approved investing in manufacturing assets for expansion and availing a loan of up to ₹ 75 crs for this purpose.
What is the maximum loan amount Anuh Pharma can avail for expansion?
Anuh Pharma can avail a loan of up to ₹ 75 crs (Rupees Seventy Five Crores) for purchasing manufacturing assets.
What is the purpose of the approved loan and investment by Anuh Pharma?
The purpose is to invest in manufacturing assets for the expansion of the company’s production capacity.
Are there any conditions for Anuh Pharma to avail the loan for expansion?
Yes, the loan is subject to finalisation of the terms and conditions and receipt of applicable approvals, wherever required.
Questions based on this BSE filing only. For information purposes.